ARTEL Extreme Pipetting Expedition to Visit Death Valley to Test Impact of Dry Heat on Laboratory Data
News Sep 07, 2007
ARTEL announces that Death Valley National Park will be the site of Mission #3 of the Extreme Pipetting Expedition. At Death Valley, located in the desert spanning Nevada and California, ARTEL will test how dry and hot environmental conditions alter pipetted volumes.
Dry heat was chosen as the scientific focus of Mission #3 because many laboratory technicians commonly encounter this condition in their work environments. For example, laboratories using analytical instruments, ovens, incubators, freezers and other devices using high power or open flames are prone to heat and low humidity. Dry heat can also be contributed by heating and air-conditioning systems not equipped with humidifiers. To ensure pipetting accuracy and precision and strengthen data integrity, it is essential that laboratory scientists understand and compensate for this source of error.
ARTEL will release the results from Mission #3 at the Association for Molecular Pathology (AMP) 2007 Annual Meeting and Exhibits (booth #54), November 7-10, 2007.
A 3.3 million acre desert, Death Valley was selected as the site for Mission #3 because it is iconic for its hot and dry climate. Surrounded by mountains, the valley captures and retains extreme amounts of heat to create one of the hottest environments on earth, commonly exceeding 49oC (120oF). Death Valley is also the driest locale in the United States, receiving fewer than two inches of rain annually.
The Extreme Pipetting Expedition is a multi-phase, year-long scientific study to illustrate the impact of laboratory environmental conditions on pipetting performance and data integrity.
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018